Skip to main content

Advertisement

Table 3 Calendar periods and distributions of lymphoma diagnoses, selected characteristics, and mortality

From: The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016

Category 1994–1999 2000–2009 2010–2016 Total
N % N % N % N %
Aggressive B-cell lymphoma 10 23.8 46 28.6 49 21.3 105 24.3
Indolent lymphoma 14 33.3 47 29.2 46 20.0 107 24.7
Of which transformed 4 28.6 31 66.0 35 76.1 70 65.4
Mantle cell lymphoma 2 4.8 27 16.8 55 23.9 84 19.4
T-cell lymphoma 6 14.3 23 14.3 37 16.1 66 15.2
Hodgkin lymphoma 10 23.8 18 11.2 23 10.0 51 11.8
Primary CNS lymphoma 0 0 0 0 20 8.7 20 4.6
Harvest < 5 million CD34 +/kg 22 64.7 36 23.2 51 22.2 109 26.0
Upfront transplantation 3 7.1 46 28.6 106 46.1 155 35.8
Age > 65 years 0 0 19 11.8 66 28.7 85 19.6
100-day overall mortality 4 9.5 14 8.7 13 5.7 31 7.2
100-day non-relapse mortality 4 9.5 11 7.0 9 4.0 24 5.6
100-day lymphoma mortality 0 0 3 2.0 4 1.8 7 1.7
6-month overall mortalitya   14.3   13.1   7.4   10.2
6-month non-relapse mortalitya   11.9   6.0   3.9   6.3
6-month lymphoma mortalitya   2.7   5.3   3.6   4.2
1-year overall mortalitya   28.6   19.9   16.6   19.0
1-year non-relapse mortalitya   17.1   6.8   4.4   7.6
1-year lymphoma mortalitya   13.8   11.5   12.8   12.4
  1. aThese values are estimated using survival analysis, why only percentages can be extracted